Diasorin molecular liaison MDX kits - delivery order

Ended Awarded Last action

Contract number
W81K0226FA042
Awardee
Awarding agency
Obligated
$61,602

Award facts

Contract value 100% obligated
$61,602.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
LEWIS MCCHORD, WA 98431, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00002 · Diasorin molecular liaison kits $0
Other Administrative Action P00001 $0
Original award $61,602

About this award

The Defense Health Agency issued a delivery order to Diasorin Molecular LLC on October 1, 2025, for Diasorin Molecular Liaison MDX diagnostic kits with a ceiling value of $61,602.00, ultimate completion September 30, 2026.

Place of performance is Lewis-McChord, WA. The order is issued on a firm fixed-price basis with no set-aside designation. Diasorin Molecular is a foreign-owned manufacturer of molecular diagnostic reagents, analyzers, and test kits, competing on full-and-open basis across its federal footprint.

Quick answers

Who was awarded contract W81K0226FA042?

W81K0226FA042 was awarded to Diasorin Molecular, LLC by Defense Health Agency (Department of Defense) on October 1, 2025.

How much is contract W81K0226FA042 worth?

The government has obligated $61,602 on W81K0226FA042.

Is contract W81K0226FA042 an order under another contract?

Yes. W81K0226FA042 is a delivery order under W81K0226DA005, an indefinite delivery contract.

Was contract W81K0226FA042 competed?

The extent of competition for W81K0226FA042 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award